GPCR Peptide Ligand Library

Abstract

GPCR Network: a large-scale collaboration on GPCR structure and function

“G protein-coupled receptors (GPCRs) are targeted by ~30–40% of marketed drugs, and their key roles in normal physiology and in disease demonstrate that an understanding of their structure and function is valuable to researchers in both basic science and drug discovery. However, until recently, detailed structural information on this protein family was limited by challenges in X-ray crystallographic analysis of such membrane proteins. The GPCR Network was created in 2010 with the goal of structurally characterizing 15–25 representative human GPCRs within 5 years, based on an active outreach programme addressing an interdisciplinary community of scientists interested in GPCR structure, chemistry and biology. Here, we provide an overview of how this collaborative effort has enabled the structural determination and characterization of eight human GPCRs so far, and discuss some of the challenges that remain in gaining more detailed insights into structure–function relationships in this receptor superfamily.

Stevens RC, Cherezov V, Katritch V, et al. Nat Rev Drug Discov. 2013;12(1):25-34.

More Information

A collection of nature-inspired design of domain-specific peptides

This library is being continuously updated to include all new and current peptides including GnRH(1-5) (GPR101 and GPR173), SDF-1-alpha (CXCR4 receptor), Ela-32 and Ela-21 (APJ), SCNH2/Apelin-prepropeptide(42-57), TLQP-21 (C3a or C1q receptor), D-[Lys3]GHRP-6 (CCR5), Neuronostatin (GPR107), Pepcan-12 (CB1) Fractalkine peptides, cysteine-modified or C-terminally truncated INSLs and truncated GLP-1Peptide 34 (GPR54), Fertilization promoting peptide (TCP11), Head Activator Neuropeptide (GPR37), Obestatin( GPR39), Neuromedin S, Neuropeptide S, QRFP-43, PBAN, P518, NPB & NPW, INSL 3 & 7, Endokinin A/B, AF9, BK), receptors (FM-4/TGR-1, NPSR, GPR100, GPR135, GPR142, GPR103, GPR7 & 8, LGR7 & 8, CG6986, NPR-1, PBAN-R) and references.
It has been suggested that several different active conformations of the receptor may exist dependent on the properties of the agonist.  Therefore, properly selection with modified peptide ligands for a biased signalling properties may allow the development of drugs that selectively modulate only the therapeutically relevant physiological functions, thereby decreasing the risk of side effects.

Related Products

Catalog
Product
Size
Price
Buy Now
L-004
G-Protein Coupled Receptor (GPCR) Peptide Ligand Library
Catalog: L-004
960 peptides
Size:960 peptides
$29,355
Price: $29,355